Trials of cardiovascular devices, including peripheral interventions, are highlighted in this month's edition of Starts & Stops, Medtech Insight's regular feature on medtech clinical trials that have started, restarted, completed, or terminated.
Mercator MedSystems Inc. announced April 26 that the first patient has been enrolled in the TANGO (Temsirolimus Adventitial Delivery to Improve Angiographic Outcomes Below the Knee) clinical...